Skip to main content
. 2021 Oct 5;129(4):664–670. doi: 10.1111/1471-0528.16917

Table 2.

Cumulative incidence of autoimmune disease, fibromyalgia or myalgic encephalomyelitis by type of surgery

Mesh group Non‐mesh group
Number of patients at risk
At time of surgery 88 947 3389
At 1 year 88 258 3351
At 5 year 84 110 3192
At 10 year 29 123 1678
Cumulative incidence of systemic diseases, % (95% CI)
At 1 year 0.6 (0.5–0.6) 0.7 (0.4–1.0)
At 5 year 3.6 (3.5–3.7) 4.0 (3.4–4.7)
At 10 year 8.1 (7.9–8.3) 9.0 (8.0–10.1)
HR (95% CI) 0.89 (0.79–1.01), P = 0.06
Cumulative incidence of autoimmune disease only, % (95% CI)
At 1 year 0.6 (0.5–0.6) 0.7 (0.4–1.0)
At 5 year 3.4 (3.3–3.6) 3.9 (3.3–4.6)
At 10 year 7.7 (7.5–7.9) 8.7 (7.7–9.7)
HR (95% CI) 0.88 (0.78–0.99), P = 0.04